Cargando…
An overview of the treatment of cutaneous leishmaniasis
Leishmaniasis is a neglected tropical disease caused by species of Leishmania, with a broad spectrum of clinical manifestations, such as cutaneous, visceral, and mucocutaneous presentations. Many drugs are used for its treatment, and a current effective one is a pentavalent antimonial, especially in...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty Opinions Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886081/ https://www.ncbi.nlm.nih.gov/pubmed/33659960 http://dx.doi.org/10.12703/r/9-28 |
_version_ | 1783651722339549184 |
---|---|
author | Garza-Tovar, Talissa F Sacriste-Hernández, Marco I Juárez-Durán, Eder R Arenas, Roberto |
author_facet | Garza-Tovar, Talissa F Sacriste-Hernández, Marco I Juárez-Durán, Eder R Arenas, Roberto |
author_sort | Garza-Tovar, Talissa F |
collection | PubMed |
description | Leishmaniasis is a neglected tropical disease caused by species of Leishmania, with a broad spectrum of clinical manifestations, such as cutaneous, visceral, and mucocutaneous presentations. Many drugs are used for its treatment, and a current effective one is a pentavalent antimonial, especially in developing countries. In this review, we discuss recent proposed therapies as well as their side effects. |
format | Online Article Text |
id | pubmed-7886081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Faculty Opinions Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-78860812021-03-02 An overview of the treatment of cutaneous leishmaniasis Garza-Tovar, Talissa F Sacriste-Hernández, Marco I Juárez-Durán, Eder R Arenas, Roberto Fac Rev Review Article Leishmaniasis is a neglected tropical disease caused by species of Leishmania, with a broad spectrum of clinical manifestations, such as cutaneous, visceral, and mucocutaneous presentations. Many drugs are used for its treatment, and a current effective one is a pentavalent antimonial, especially in developing countries. In this review, we discuss recent proposed therapies as well as their side effects. Faculty Opinions Ltd 2020-12-22 /pmc/articles/PMC7886081/ /pubmed/33659960 http://dx.doi.org/10.12703/r/9-28 Text en Copyright: © 2020 Arenas R et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Garza-Tovar, Talissa F Sacriste-Hernández, Marco I Juárez-Durán, Eder R Arenas, Roberto An overview of the treatment of cutaneous leishmaniasis |
title | An overview of the treatment of cutaneous leishmaniasis |
title_full | An overview of the treatment of cutaneous leishmaniasis |
title_fullStr | An overview of the treatment of cutaneous leishmaniasis |
title_full_unstemmed | An overview of the treatment of cutaneous leishmaniasis |
title_short | An overview of the treatment of cutaneous leishmaniasis |
title_sort | overview of the treatment of cutaneous leishmaniasis |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886081/ https://www.ncbi.nlm.nih.gov/pubmed/33659960 http://dx.doi.org/10.12703/r/9-28 |
work_keys_str_mv | AT garzatovartalissaf anoverviewofthetreatmentofcutaneousleishmaniasis AT sacristehernandezmarcoi anoverviewofthetreatmentofcutaneousleishmaniasis AT juarezduranederr anoverviewofthetreatmentofcutaneousleishmaniasis AT arenasroberto anoverviewofthetreatmentofcutaneousleishmaniasis AT garzatovartalissaf overviewofthetreatmentofcutaneousleishmaniasis AT sacristehernandezmarcoi overviewofthetreatmentofcutaneousleishmaniasis AT juarezduranederr overviewofthetreatmentofcutaneousleishmaniasis AT arenasroberto overviewofthetreatmentofcutaneousleishmaniasis |